I-Xifaxan (rifaximin) i-antibiotics e-FDA-yamkelwe ukunyangwa kwehudo-eyona nto ikhubaza isifo sesisu (IBS-D), kunye ne- diarrhea . I-Xifaxan iye isetyenziselwa ukunyamekela i-britney intestinal overgrowth ( SIBO ).
I-Xifaxan isebenza njani?
I-Xifaxan ithathwa ngomlomo, kathathu ngosuku ngexesha leveki ezimbini. Ukuba uncedo olusaneleyo lweempawu aluphumelelanga, amayeza angaphindwa ngokuphindaphindiweyo ukuya kwiikhosi ezili-14 ngaphezulu kweentsuku ezili-14.
I-Xifaxan ayifakwanga esiswini kwaye ngaloo ndlela kucingelwa ukuba yenze kwiibhaktheriya ezifumaneka emathunjini amancinci amakhulu. Umgangatho ongabonakaliyo wezinto ze-Xifaxan kwimiphumo encinci emzimbeni ngokubanzi.
Imiphumela
I-Xifaxan ivame ukunyamezela. Kwizilingo zeekliniki, iziphumo ezimbi ezibi zihlala zihambelana nezo zendawo. Iziphumo ezincinci zecala ziye zabikwa:
- Ukutyunjwa
- Utywala
- Intloko
- Isihlunu kunye / okanye ukuhlanza
Ngaba ufanele ufumane nayiphi na imiphumo emibi elandelayo xa uthatha i-Xifaxan, kufuneka uqhagamshelane nodokotela wakho ngokukhawuleza:
- Iimpawu zokugula, ezifana nobunzima bokuphefumla; imisango, ukubetha okanye ukukhawuleza; okanye ukuvuvukala kwemilomo, ubuso okanye ulwimi
- Fever
- Umhudo wamanzi okanye igazi
I-FDA ikhuthaza ukuba ukuba iyeza lithintela iimpawu zokurhudo, kufuneka uhlolwe ngentsholongwane kaC C ..
I-Xifaxan ayifanele isetyenziswe ukuba unobungozi obukhulu besibindi.
Ngaba i-Xifaxan iphumelele kwi-IBS?
Izilingo zezonyango kuze kube yiminyaka zibonise ukuba i-Xifaxan iphumelele ngakumbi kune-placebo ekunciphiseni iimpawu zesisu esiswini kunye nokuphucula isimo esifanelekileyo.
Uphando olusondeleyo luye lwabonisa ukuba i-Xifaxan iyakunyamezeleka kwaye ibonakala ikhuselekile ukusetyenziswa kwexesha elifutshane. Abanye abantu bangadinga iikholeji ezingaphezulu kweyodwa ukwenzela ukuphumeza iziphumo ezifunwayo.
Imithombo:
"I-FDA iyavuma imigaqo emibini yokuphatha i-IBS-D" I- FDA News Announcement May 27, 2015.
I-Ford, A., ne.al. "I- American College ye-Gastroenterology Monograph kwi-Management of Irritable Bowel Syndrome kunye ne-Chronic Idiopathic Constipation " I- American Journal ye-Gastroenterology 2014 109: iS2-S26.
Gaman, A., Bucur, M. & Kuo, B. Ukuphuluka kwezilwanyana kwizifo zesisu esisisigxina: isifo sengqondo esisilumkileyo. Uphuhliso lwezonyango kwi-Gastroenterology, 2009 2: 169-181.